Please login to the form below

Not currently logged in
Email:
Password:

US recall of four children's products

Blacksmiths Brands has announced the recall of four children's products in the PediaCare line in the US

Blacksmiths Brands has announced the recall of four children's products in the PediaCare line in the US.

The voluntary recall comes after consultation with the US Food and Drug Administration (FDA) in what Blacksmiths Brands described as a 'precautionary step'.

The products had all been manufactured at the McNeil Consumer Healthcare Fort Washington, Pennsylvania, which has been temporarily shut down following an FDA inspection that found serious violations of the agency's good manufacturing practice requirements. McNeil Consumer Healthcare is a subsidiary of Johnson & Johnson.

The products involved in the recall are PediaCare Multi-Symptom Cold 4oz, PediaCare Long Acting Cough 4oz, PediaCare Decongestant 4oz and PediaCare Allergy and Cold 4oz.

In a statement, the company said: "the recall was not initiated as a result of any consumer reports of adverse events and no consumer complaints have been received about the safety or purity of the products."

Blacksmiths Brands have however advised customers who own any of the recalled products to dispose of them.

Peter Man, chairman and CEO of the company, said: "We're taking this voluntary step because protecting consumers and maintaining their trust are essential to our company's core values."

New arrangements for the manufacture of the recalled products have been made, with shipments expected to resume in July.

1st June 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Harness the power of data to map new patient pathways
Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset...
What NORD’s RareInsights® 30-year comparative analysis means to us and our clients at OPEN Health
...
Peter Jackson
Rethinking our approach to infectious disease preparedness
The importance of long-term strategic investment to prepare for the next threat that emerges...

Infographics